10X Genomics, Inc. (TXG)
93.50
+4.74
(+5.34%)
USD |
NASDAQ |
Oct 02, 16:00
94.00
+0.50
(+0.53%)
After-Hours: 20:00
10X Genomics Market Cap : 12.18B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 12.18B |
| October 01, 2026 | 11.56B |
| September 30, 2026 | 11.77B |
| September 29, 2026 | 11.73B |
| September 28, 2026 | 11.53B |
| September 25, 2026 | 11.17B |
| September 24, 2026 | 10.96B |
| September 23, 2026 | 9.852B |
| September 22, 2026 | 10.51B |
| September 21, 2026 | 10.31B |
| September 18, 2026 | 9.980B |
| September 17, 2026 | 10.03B |
| September 16, 2026 | 9.469B |
| September 15, 2026 | 9.692B |
| September 14, 2026 | 9.134B |
| September 11, 2026 | 8.936B |
| September 10, 2026 | 8.648B |
| September 09, 2026 | 8.767B |
| September 08, 2026 | 8.547B |
| September 04, 2026 | 8.162B |
| September 03, 2026 | 8.236B |
| September 02, 2026 | 8.032B |
| September 01, 2026 | 7.814B |
| August 31, 2026 | 8.136B |
| August 28, 2026 | 8.018B |
| Date | Value |
|---|---|
| August 27, 2026 | 8.449B |
| August 26, 2026 | 8.372B |
| August 25, 2026 | 8.432B |
| August 24, 2026 | 8.312B |
| August 21, 2026 | 8.484B |
| August 20, 2026 | 8.321B |
| August 19, 2026 | 8.102B |
| August 18, 2026 | 7.248B |
| August 17, 2026 | 7.555B |
| August 14, 2026 | 7.308B |
| August 13, 2026 | 7.576B |
| August 12, 2026 | 7.524B |
| August 11, 2026 | 7.619B |
| August 10, 2026 | 7.631B |
| August 07, 2026 | 6.779B |
| August 06, 2026 | 5.941B |
| August 05, 2026 | 6.183B |
| August 04, 2026 | 6.235B |
| August 03, 2026 | 6.064B |
| July 31, 2026 | 6.097B |
| July 30, 2026 | 6.376B |
| July 29, 2026 | 5.975B |
| July 28, 2026 | 6.069B |
| July 27, 2026 | 5.923B |
| July 24, 2026 | 5.968B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 11.82B |
| Tempus AI, Inc. | 13.80B |
| Personalis, Inc. | 1.732B |
| Alamar Biosciences, Inc. (California) | 2.384B |
| Beam Therapeutics, Inc. | 2.530B |
Market Cap Related Metrics
| PS Ratio | 19.36 |
| Price to Book Value | 14.76 |
| Price to Free Cash Flow | 98.33 |
| Price | 93.50 |
| Earnings Yield | -0.63% |